One Stock Chart Trick You Should All Know - Investment Ideas
David Bartosiak - ZACKS - Tue Dec 16, 12:00AM CST
One Stock Chart Trick You Should All Know - Investment Ideas
HSKA: 18.13 (+0.24), ANIP: 55.24 (+1.79), SCMP: 13.75 (+0.44)
Heska to Attend Benchmark Micro Cap Discovery Conference
PR Newswire - Tue Nov 25, 3:01PM CST
Heska Corporation (NASDAQ: HSKA) - (News; "Heska" or the "Company"
HSKA: 18.13 (+0.24)
Why Intercept Pharmaceuticals (ICPT) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 7:40AM CST
Intercept Pharmaceuticals has witnessed a significant price decline in the past four weeks and negative earnings estimate revisions for the current quarter and the current year, making it time for investors to sell it off
HSKA: 18.13 (+0.24), ICPT: 151.49 (+5.85), AMAG: 43.02 (+0.90), DYAX: 14.13 (+0.30)
Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 4:20PM CST
On Nov 21, Zacks Investment Research upgraded Illumina Inc. (ILMN) to a Zacks Rank #1 (Strong Buy).
BIIB: 340.89 (+5.13), HSKA: 18.13 (+0.24), ILMN: 186.22 (+2.72), AFFX: 9.80 (+0.05)
Heska analyst day leaves Feltl bullish
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 2:45PM CST
HSKA: 18.13 (+0.24), ABAX: 58.48 (+0.22), IDXX: 148.68 (+1.45)
Achillion Pharmaceuticals (ACHN) Looks Strong: Stock Up 27.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 7:44AM CST
Achillion Pharmaceuticals (ACHN) was a big mover last session, as the company saw its shares surge a little over 27% on the day
HSKA: 18.13 (+0.24), ACHN: 13.06 (+1.22), ILMN: 186.22 (+2.72), AFFX: 9.80 (+0.05)
Achillion Pharmaceuticals Slumps: ACHN Plunges 15.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 7:34AM CST
Achillion Pharmaceuticals (ACHN) fell nearly 16% in the last trading session amid huge volumes, reversing its recent trend, as the stock is now up nearly 3% in the past one month.
AGEN: 3.85 (unch), HSKA: 18.13 (+0.24), ACHN: 13.06 (+1.22), AMAG: 43.02 (+0.90)
Heska Announces Investor Day in New York City
PR Newswire - Tue Nov 04, 8:00AM CST
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
HSKA: 18.13 (+0.24)
Qiagen Q3 Earnings, Revenues in Line; Outlook Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:50PM CDT
Qiagen's (QGEN) strategic collaborations, test menu expansions and moderately balanced international expansion will likely drive growth over time.
BIIB: 340.89 (+5.13), HSKA: 18.13 (+0.24), ILMN: 186.22 (+2.72), QGEN: 23.20 (+0.09)
Can the Rally in Heska (HSKA) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:06AM CDT
Can the Rally in Heska (HSKA) Shares Continue?
HSKA: 18.13 (+0.24)
Heska's (HSKA) CEO Kevin Wilson on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 7:40PM CDT
HSKA: 18.13 (+0.24)
Heska ups earnings 113% in Q3
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 2:09PM CDT
HSKA: 18.13 (+0.24)
Heska beats by $0.09, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 8:04AM CDT
HSKA: 18.13 (+0.24)
Heska Reports 24% Revenue Growth, $0.08 Per Share for the Third Quarter of 2014
PR Newswire - Wed Oct 29, 8:00AM CDT
Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"
HSKA: 18.13 (+0.24)
Heska Signs Distribution Agreement with Henry Schein Animal Health
PR Newswire - Wed Oct 29, 7:45AM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
HSKA: 18.13 (+0.24), HSIC: 137.87 (+0.15)
Webcast Alert: Heska Announces Third Quarter 2014 Earnings Conference Call Webcast
PR Newswire - Tue Oct 28, 3:30PM CDT
Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
HSKA: 18.13 (+0.24)
Repros Therapeutics (RPRX) Worth Watching: Stock Up 17% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 8:46AM CDT
Repros Therapeutics (RPRX) was a big mover last session, with shares surging almost 17% on the day.
CBM: 21.62 (+0.37), HSKA: 18.13 (+0.24), GILD: 91.29 (+1.84), RPRX: 8.88 (+0.24)
Cyclacel Pharmaceuticals (CYCC) in Focus: Stock Jumps 5.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 8:21AM CDT
Cyclacel Pharmaceuticals, Inc. (CYCC) was a big mover last session, as the company saw its shares rise by over 5% on the day.
HSKA: 18.13 (+0.24), CBM: 21.62 (+0.37), CYCC: 0.69 (+0.01), GILD: 91.29 (+1.84)